Industry News

Henry Schein, Inc. announced today that Dr. Adriana Noacco is the recipient of the fourth annual Henry Schein Cares International Veterinary Community Service Award in recognition of her service to people living in poverty in Argentina. Noacco received the award at the gala dinner of the 2016 World Small Animal Veterinary Association World Congress, held in Cartagena, Colombia."/>
Henry Schein Bestows Fourth Annual International Veterinary Community Service Award On Argentina's Dr. Adriana Noacco
GN Audio (Jabra) has acquired VXi and BlueParrott
HCA Holdings, Inc. announces the following Webcast:. If you are unable to listen during the live webcast, the call will be archived on the web site View source version on"/>
HCA 3rd Quarter 2016 Earnings Conference Call
Cannabis Science, Inc., a U.S. company specializing in the development of cannabis-based medicines, feels empowered to be based in California, representing one of the largest cannabis markets in the USA, on the eve of what could be one of the most important cannabis votes yet: California vote yes to Proposition 64.. If Proposition 64 passes, the company expects public perception of cannabis use to improve dramatically; in addition, the drug will become easier to..."/>
Excitement for Proposition 64 Mounts in California and Propels Cannabis Science to Release More New Products While Discharging Stigmas by Legalizing Use of Cannabis in the State of California
Catalyst Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that Patrick J. McEnany, Chief Executive Officer, and Steven Miller, Ph.D., Chief Operating Officer and Chief Scientific Officer, will present at the 15th Annual BIO Investor Forum being held at the Westin St. Francis in San Francisco, October 18-19.."/>
Catalyst Pharmaceuticals to Present at 15th Annual BIO Investor Forum
Alliqua BioMedical Inc. based in Yardley, Pa. The move allows Soluble's 60 employees and some senior management to continue working as part of a larger company capable of taking the business's growth to the next level, Soluble Systems CEO Allan Staley said. "This is a combination of two companies to form a stronger, more viable, powerful..."/>
Homegrown Newport News biotech company to join up with partner for growth [Daily Press (Newport News, Va.)]
Aetna announced a collaboration to create an oncology medical home that is designed to improve the care experience for cancer patients. In the oncology medical home model, teams of cancer specialists collectively provide a patient's health care when he or she has a cancer diagnosis. The model will give RCCA the responsibility to arrange appropriate care that is continuous and proactive..."/>
Regional Cancer Care Associates And Aetna Form Oncology Medical Home
Interpace Diagnostics Group, a company that provides specialized molecular diagnostic tests and pathology services for evaluating risk of cancer, completed the validation and launch of two new thyroid services, further expanding the Company's comprehensive support of physicians and health care institutions servicing thyroid patients. The Company expects the new service offerings will generate an estimated 400 new specimens in..."/>
Interpace Diagnostics Launches New Services for Indeterminate Thyroid Nodules
Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, has received preliminary approval for a $2.7 million tax credit from the New Jersey Economic Development Authority’ s New Jersey Technology Business Tax Certificate Transfer program. The company anticipates it will be able to transfer this credit and receive more than $2.5 million in cash by the end of 2016.. This competitive program– administered by the NJEDA–..."/>
Advaxis to Receive $2.5M through the New Jersey Economic Development Authority NOL Program
Veracyte, Inc., a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic uncertainty, announced that external researchers will present data from three studies reinforcing the clinical impact and value of the company's Percepta ® Bronchial Genomic Classifier and Envisia™ Genomic Classifier– for use in lung cancer and idiopathic pulmonary fibrosis diagnosis,..."/>
Data Demonstrating Clinical Value of Veracyte Genomic Tests for Use in Lung Cancer and IPF to Be Presented at CHEST Annual Meeting 2016
Medovex Corp., a developer of medical technology products, today announced that the Company successfully exhibited its' DenerveX™ System during EuroSpine 2016 Tradeshow last week in Berlin, Germany. As part of the product exhibition, Medovex highlighted its innovative DenerveX™ System, a minimally invasive surgical procedure pioneered by Medovex that was built around the denervation of the posterior capsulectomy of the Facet Joint using our patented..."/>
Medovex Corporation Reports Successful Demonstration of Expanding EMEA Business at EuroSpine 2016, Berlin, Germany
Corium International, Inc., a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Robert Breuil, Corium’ s Chief Financial Officer, will present at the Dawson James Securities Growth Stock Conference in Jupiter, Florida, on Thursday, October 20, 2016 at 8:30 a.m. Eastern time. Corium International, Inc. is a commercial-stage..."/>
Corium to Present at Dawson James Securities Growth Stock Conference
Vocera Communications, Inc. today announced that it expects to release results for its third quarter 2016 on Thursday, Oct. 27, after market close. In conjunction with a press release, management will host a conference call at 5 p.m. A free, live webcast of the conference call will be available on the Investors section of the company’ s website at"/>
Vocera Q3 2016 Results to be Released October 27, 2016
Mast Therapeutics, Inc., today announced that the Company's Chief Executive Officer, Brian M. Culley, will provide an update related to its business strategy and clinical development of its product candidates at the 2016 BIO Investor Forum on Wednesday, October 19, 2016 at 2:30 p.m. Pacific time in the Elizabethan B Salon at the Westin St. Francis hotel in San Francisco. The Company recently announced a strategic focus on its AIR001 program with..."/>
Mast Therapeutics To Present At 2016 BIO Investor Forum On October 19th
T2 Biosystems, Inc., a company developing innovative diagnostic products to improve patient health, today announced the Company’ s T2 Magnetic Resonance technology in detecting early-stage Lyme disease and T2Candida ® Panel in rapid sepsis detection will be the focus of five poster presentations during IDWeek 2016. The conference, hosted by the Infectious Diseases Society of America, will take place October 26-30 in New Orleans.."/>
T2 Biosystems Announces Presentations at IDWeek 2016
Natera, a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it will present data from Horizon™ carrier screen and Spectrum ® pre-implementation genetic screening studies at the Annual Meeting of the American Society for Reproductive Medicine Conference in Salt Lake City on Oct. 15-19, 2016. The diverse set of data that will be presented at the conference includes a PGS study on..."/>
Natera Announces Two Poster Presentations on Triploidy and Duchenne Muscular Dystrophy to be Featured at the 2016 American Society for Reproductive Medicine (ASRM) Conference
Eiger BioPharmaceuticals, Inc, today announced that abstracts from its LOWR HDV Program will be presented at the American Association for the Study of Liver Diseases meeting in Boston, Massachusetts, November 11 to 15, 2016. Twenty-four-week data from the phase 2 LOWR HDV Program will be presented. Accepted AASLD abstracts are listed below:."/>
Eiger Announces Abstracts and Presentations of LOWR HDV Program at the American Association for the Study of Liver Diseases (AASLD) Meeting
Caladrius Biosciences disclosed on Wednesday the election of Gregory R Brown, MD, to its board of directors. Currently, Dr Brown is the chairman of the company's audit committee as well as a member of the nominating and governance committee. He is a co-founder and vice chairman of HealthCare Royalty Partners."/>
Caladrius Biosciences names Gregory R Brown, MD to board
Pacific Biosciences of California, Inc. will hold its quarterly conference call to discuss its Third Quarter 2016 Financial Results on Wednesday, November 2, 2016, at 4:30pm Eastern Time.. The call will be webcast and may be accessed at Pacific Biosciences’ website at: About Pacific Biosciences Pacific Biosciences of California, Inc. offers sequencing systems to help scientists resolve genetically..."/>
Pacific Biosciences of California, Inc. Third Quarter 2016 Financial Results Call
Horizon Pharma plc, a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that Horizon Pharma, Inc. and Horizon Pharma USA, Inc., its wholly owned subsidiaries, intend, subject to market and other considerations, to offer $300 million aggregate principal amount of senior notes due 2024,..."/>
Horizon Pharma plc Announces Proposed Private Offering of Senior Notes and Intention to Borrow Incremental Term Loans under its Existing Senior Secured Credit Facility
Community Health Spinoff. Demonstrates how Quorum’ s Unprecedented Adjusted EBITDA Miss and Guidance Adjustment in August 2016 was Significantly Driven by Factors Well Known to Community Health Management During the Marketing of the Spin Off. Actions Taken by Quorum and Community Health Have Caused at Least $560 million of Value Destruction."/>
Q Investments Calls for Quorum Health Corporation Board to Conduct Independent Investigation into Possible Fraudulent Disclosure Regarding its Spin-Off from Community Health Systems

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology797 Articles
Consumer Discretionary705 Articles
Financials691 Articles
Industrials541 Articles
Health Care516 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at